First-line treatments in EGFR-mutated advanced non-small cell lung cancer: A network meta-analysis

BACKGROUND: It remains unknown which is the optimal first-line treatment regimen for patients with advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). We performed a network meta-analysis to address this important issue. METHODS: PubMed, Embase, Cochrane Libr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongwei, Chen, Jun, Liu, Tingting, Dang, Jun, Li, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776360/
https://www.ncbi.nlm.nih.gov/pubmed/31581247
http://dx.doi.org/10.1371/journal.pone.0223530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776360/
https://www.ncbi.nlm.nih.gov/pubmed/31581247
http://dx.doi.org/10.1371/journal.pone.0223530

Ejemplares similares